Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

National Academies: NTP's Conclusion about Fluoride Is Not Backed by Science

American Fluoridation Society Comments on This New Report


News provided by

American Fluoridation Society

Mar 11, 2020, 11:11 ET

Share this article

Share toX

Share this article

Share toX

WASHINGTON, March 11, 2020 /PRNewswire/ -- Last September, the National Toxicology Program (NTP) released a draft monograph concluding that "fluoride is presumed to be a cognitive neurodevelopmental hazard to humans." Before finalizing its monograph, NTP asked a committee of the National Academies of Sciences, Engineering and Medicine to review its conclusion and decide whether it is supported by the scientific evidence. In a new report, the Committee finds that NTP's monograph failed to provide adequate support for its conclusion.

The National Academies committee voiced "substantive concerns" with how NTP evaluated the human evidence in the draft of its Systematic Review of Fluoride Exposure and Neurodevelopmental and Cognitive Health Effects. The Committee wrote that NTP "needs to state clearly that the monograph is not designed to be informative regarding decisions about fluoride concentrations for water fluoridation."

The NTP draft monograph stated that its conclusion was based primarily on fluoride exposure levels that are roughly double the concentration used for community water fluoridation.  Nonetheless, the NTP document raised concern among many public health leaders and dental professionals who worried that NTP's conclusion might create needless fear or confusion among the public.

"This report by the National Academies makes it clear that NTP's conclusion was not backed up by solid science. Tooth decay is the most common chronic disease among children, and agencies like this need to be careful and cautious before they arrive at weak conclusions that could potentially scare children and adults away from fluoride in water, toothpaste or other products," said Dr. Johnny Johnson, a pediatric dentist who is president of the American Fluoridation Society, a nonprofit 501(c) 4 organization.

The National Academies committee was not asked to adopt a position as to whether fluoride is safe or not. Instead, the Committee was given one task — evaluate NTP's draft monograph by assessing whether its conclusion accurately reflects the scientific literature. The Committee's report stated that NTP would need to conduct and present more analysis before it could reach and support a conclusion about fluoride's effect on neurodevelopment.

Throughout its report, the National Academies committee raises concerns with numerous areas of the NTP monograph. The Committee's concerns include the following:

  • The studies included in NTP's systematic review "did not undergo rigorous statistical review" and called this "problematic" because some of these studies had issues or errors that "compromised their internal validity."
  • NTP appeared to have applied its "risk of bias" criteria inconsistently.
  • NTP failed to address the misclassification of fluoride exposure "thoroughly and consistently," raising the question of whether NTP's evaluations "were sufficient and supported its conclusion."
  • Researchers should consider potential confounding as they design and analyze a study to ensure that an association is not attributed by error to the wrong variable. With this in mind, the National Academies report identified "many cases in which NTP's evaluation of confounding was insufficient, difficult to understand, or applied inconsistently across studies."
  • NTP classified some studies as having a low risk of bias even though "the measure of the neurodevelopmental and cognitive outcome was seriously flawed."
  • NTP's protocol did not disclose the inclusion and exclusion criteria it used for selecting the studies it considered in drafting its monograph. Clarity in this area is "critical for transparency of the process and reproducibility of the findings."

One of the more disturbing concerns raised by the National Academies committee was NTP's decision to use a group called the Fluoride Action Network (FAN) as a source to identify relevant literature. "The process by which FAN identified and selected studies is unclear," the Committee writes, "and that uncertainty raises the question of whether the process could have led to a biased selection of studies. Such a concern raises the need for a formal evaluation of any potential bias that might have been introduced into the literature-search process."

The NTP decision to establish this relationship with FAN is astonishing considering the following facts:

  • FAN is not a "research" organization.  It uses the web and social media to disseminate messages encouraging local communities to oppose community water fluoridation.  Additionally, FAN is one of the leading plaintiffs in a federal lawsuit seeking to ban a leading type of fluoride additive that is used for CWF.
  • FAN has demonstrated a lack of scientific rigor through its interactions with federal health agencies. In 2003, Environmental Protection Agency (EPA) officials evaluated a set of research articles that FAN had submitted to support its objections to the Sulfuryl Fluoride Pesticide Tolerance Rule. In its evaluation, EPA found that most of the FAN articles "did not require a detailed review" because they suffered from one or more weaknesses, including articles with no toxicity data, articles lacking a clear explanation of methodologies, and papers "that did not contain any data on fluoride."
  • FAN has a history of making false or inaccurate statements related to fluoride or fluoridation. In fact, the Pew Center on the States identified multiple occasions in which FAN's content included deceptive language.

The weeks that followed the release of the NTP draft monograph demonstrated how poorly NTP misjudged FAN's integrity and intentions. Within days of the monograph's release, FAN and other fluoridation opponents used social media and web-based messages in an effort to scare the public about fluoride. This inflammatory headline on FAN's website home page is only one example. Even worse, the photo that accompanied the FAN home-page story wrongly implied that the NTP monograph was a finished document that had been commercially printed for distribution.

No one can credibly argue that FAN's actions were innocent. NTP's monograph included a statement on its page headers that cautioned readers from interpreting the document as an approved policy or final document. This disclaimer advised readers that the "DRAFT Monograph" — using all caps for the word 'draft' — was being distributed "solely for the purpose of pre-dissemination peer review and does not represent and should not be construed to represent any NTP determination or policy." FAN ignored this disclaimer.

For more information about the American Fluoridation Society, visit https://americanfluoridationsociety.org/.

Contact: Dr. Johnny Johnson at 352-658-0441
or [email protected]

SOURCE American Fluoridation Society

Related Links

https://americanfluoridationsociety.org

21%

more press release views with 
Request a Demo

Modal title

Also from this source

FDA is placing unnecessary restrictions on fluoride supplements, says American Fluoridation Society

FDA is placing unnecessary restrictions on fluoride supplements, says American Fluoridation Society

After signaling its intent to deny parents access to fluoride supplements, the Food and Drug Administration (FDA) decided Oct. 31 to allow continued...

Federal agencies are taking misguided anti-fluoride steps that will harm the public's health, says American Fluoridation Society

Federal agencies are taking misguided anti-fluoride steps that will harm the public's health, says American Fluoridation Society

Tooth decay is the most common chronic disease of U.S. children and adults. Health and Human Services Secretary Robert F. Kennedy Jr. said he wants...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Dentistry

Dentistry

Surveys, Polls and Research

Surveys, Polls and Research

Children

Children

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.